$AMRN - $CRWD- On our trading list with news today or analyst comments with our opinion & trade ideas. Amarin initiated at Piper with an Overweight and $21 target. Crowdstrike price target raised to $130 from $110 at JMP Securities.Amarin initiated with an Overweight at Piper SandlerPiper Sandler analyst Yasmeen Rahimi initiated coverage of Amarin with an Overweight rating and $21 price target, which represents 210% potential upside. Amarin is the leading prescription omega-3 drug company, with Vascepa approved in 2012 for reduction of triglycerides in patients with severe hypertriglyceridemia, Rahimi tells investors in a research note. With European approval of Vascepa expected to be decided in early 2021, combined with the company's "well-capitalized position and a strong commercial sales and marketing strategy set up significant share appreciation in the near-term," says the analyst.Our Take: Amarin remains relatively an undervalued stock, accumulate under $8. Also sell some puts.Crowdstrike price target raised to $130 from $110 at JMP SecuritiesJMP Securities analyst Erik Suppiger raised the firm's price target on Crowdstrike to $130 from $110 and keeps an Outperform rating on the shares as part of a broader research note on Cybersecurity & IT Infrastructure. The analyst is citing his discussions with vendors that indicate the demand for "next-generation" end-point security is "robust", with the company seen as extending its lead in the market.Our Take: Crowdstrike is in the right business in current times, demand is there. $CRWD, CrowdStrike Holdings, Inc. / H1 Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page. .Are you interested in trading stocks to supplement your income or make a living? Maybe become a professional trader? Many traders have the skills and nerves to trade, but not the upfront capital. Well now that problem is solved!Try2BeFunded has expanded its trading program! If you're a novice or experienced trader, you can earn access to a trading account with up to $100,000! To learn more about how to qualify, click HERE and give it a shot! You have nothing to lose it is free to try. Trade Try2BeFunded today! .